2m 2m 2m 2m 2m 2m 2m
AMYLYX PHARM (AMLX)
NASDAQ
$17.17-$0.25 (-1.41%)
Price as of Jul 14, 2026 4:18 AM EDT- $2.0BMarket Cap
- 107.02%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMYLYX PHARM (AMLX)
$17.17-$0.25 (-1.41%)
AMLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.41 | ||
Change | -$0.36 (-2.03%) | ||
Open | $17.51 | ||
High | $17.53 | ||
Low | $16.96 | ||
Previous Close | $17.77 | ||
Volume | 1,468,236 | ||
30-Day Average Volume | 1,794,721 | ||
1-Week Change | -3.12% | ||
1-Month Change | 19.33% | ||
1-Year Change | 107.02% | ||
3-Year Change | -24.30% | ||
5-Year Change | 81.17% | ||
Fundamentals | |||
Shares Outstanding | 111.2M | ||
Total Assets | $293.6M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$41.3M | ||
Free Cash Flow | -$36.9M | ||
EBIT | -$41.3M | ||
EBITDA | -$41.2M | ||
Net Working Capital | $269.1M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -48 | ||
PEG | 2 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 03/28/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue